THERAPEUTIC AGENT FOR SUPPRESSION OF SNORE NOISE Russian patent published in 2005 - IPC

Abstract RU 2243783 C2

FIELD: medicine.

SUBSTANCE: invention proposes agent for suppression of snores noise designated for intramuscular administration. Agent comprises the highly purified clostridium toxin BONT/A or highly purified clostridium toxins BONT/B, BONT/C1, BONT/D, BONT/E, BONT/F and/or BONT/G. Also, agent can be used comprising a fused protein that involves light subunit of clostridium toxins among the group BONT/A, BONT/B, BONT/C1, BONT/D, BONT/E, BONT/F, BONT/G, TeNT, and heavy subunit of another clostridium toxin from the same group, or mixture of fused proteins, or complex comprising clostridium toxin or a fused protein, and one or more therapeutically good tolerable hemagglutinin, and/or one or more pharmaceutically good tolerable nontoxic protein. The proposed therapeutic agent expands assortment of medicinal agent used in the snore therapy. Invention can be used for suppression of snore noise.

EFFECT: enhanced effectiveness of agent.

10 cl, 3 ex

Similar patents RU2243783C2

Title Year Author Number
BIOPREPARATIONS COMPOSITIONS FOR INTRAVESICAL INSTILLATION 2015
  • Forssen Erik A.
  • Khyuz Patrik M.
  • Rupp Devid S.
RU2720991C2
HYBRID NEUROTOXINS 2017
  • Fonfria Subiros, Elena
  • Burgin, David
RU2782382C2
LIQUID COMPOSITION OF NEUROTOXIN STABILIZED WITH TRYPTOPHAN OR TYROSINE 2017
  • Yarstad, Anders
  • Friis, Anna
  • Shtal, Ulf
  • Gurell, Ann
  • Agren, Barbro
  • Edstrom, Emiliya
  • Pikett, Endryu
RU2741497C2
HYBRID PROTEIN FOR INHIBITION OF DEGRANULATION OF MASTOCYTES AND ITS APPLICATION 1999
  • Bigal'Ke Khans
  • Frevert Jjurgen
RU2214420C2
COMPOSITIONS AND METHODS FOR TOXIGENIC TESTING 2012
  • Dzhonson Erik Artur
  • Pellett Sabin
  • Uajtmarsh Regina Kler Mejer
  • Tepp Uillyam Govard
RU2616281C2
CLOSTRIDIAL NEUROTOXINS WITH MODIFIED PERSISTENCE 2009
  • Frevert Jurgen
RU2524429C2
SUPPRESSION OF ALLODYNIA INDUCED BY BONE CANCER 2019
  • Kalinichev, Mikhail
  • Favre, Christine
RU2791640C2
GANGLIOSIDES FOR STANDARDIZING AND INCREASING CELL SENSITIVITY TO BOTULINUM NEUROTOXINS IN IN VITRO TEST SYSTEMS 2015
  • Ejzele Karl-Khajnts
  • Mander Gerd
RU2694191C2
COMPOSITIONS AND METHODS FOR IMPROVING DRUG THERAPY WITH METAL ION DEPENDANT AGENTS 2010
  • Soparkar Charles N. S.
RU2540520C2
RECOMBINANT PROTEIN EXPRESSION IN DOUBLE-STRAND C FORM 2006
  • Shpekht Fol'Ker
RU2412253C2

RU 2 243 783 C2

Authors

Bigal'Ke Khans

Frefert Jjurgen

Dates

2005-01-10Published

1999-12-10Filed